Skip to search boxSkip to navigationSkip to main content

Tryptophan-Kynurenine Pathway in COVID-19-Dependent Musculoskeletal Pathology: A Minireview

*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Open access

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), affecting multiple organ systems, including the respiratory tract and lungs. Several studies have reported that the tryptophan-kynurenine pathway is altered in COVID-19 patients. The tryptophan-kynurenine pathway plays a vital role in regulating inflammation, metabolism, immune responses, and musculoskeletal system biology. In this minireview, we surmise the effects of the kynurenine pathway in COVID-19 patients and how this pathway might impact muscle and bone biology.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Original language

English (US)

Article number

2911578

Journal (Volume, Issue Number)

Mediators of Inflammation (Volume 2021)

Publication milestones

  • Published - 2021

Publication status

Published - 2021

ISSN

0962-9351

Publication IDs

  • Scopus: 85117400203
  • PubMed: 34621138

Publication metrics

Metrics

Fractional count
7
Fractional count
0.70
Fractional count
3
Fractional count
0.30
Fractional count
7
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
37
Social media
30
Citation count
19

Funding Details

FunderFunding number
NIA
P01AG036675